Skip to content
2000
Volume 10, Issue 1
  • ISSN: 1573-3963
  • E-ISSN: 1875-6336

Abstract

Neonatal brain injury remains a devastating condition, with poor outcomes despite the institution of an effective neuroprotective strategy of therapeutic hypothermia. There is an urgent need to develop additional neuroprotective strategies and to tailor our clinical predictive ability for families and their infants. Such goals could be more readily achieved if reliable early clinical indicators or biomarkers existed. This review will explore the relation between magnetic resonance (MR) imaging biomarkers and the degree of brain pathology observed in our translational piglet model of perinatal asphyxia. We also suggest biomarker relevance at a cellular level. The review will describe the development needed to optimize and simplify the use of biomarkers to speed up future trials of neuroprotection.

Loading

Article metrics loading...

/content/journals/cpr/10.2174/157339631001140408120613
2014-02-01
2025-05-28
Loading full text...

Full text loading...

/content/journals/cpr/10.2174/157339631001140408120613
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test